Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effect of Estrogen on Th1, Th2 and Th17 Cytokine Production by Proteolipid Protein and PHA Activated Peripheral Blood Mononuclear Cells Isolated from Multiple Sclerosis Patients.
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
MSer – A new, neutral descriptor for someone with multiple sclerosis
Laquinimod CHMP/EMA opinion
Tumefactive MS lesions under fingolimod: A case report and literature review.
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6-Mediated Signaling.
Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy.
European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil.
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
Relapses in patients treated with fingolimod after previous exposure to natalizumab.
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Myotonic dystrophy type 2 and multiple sclerosis: Case report.
Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon Beta treatment.
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord.
MARINOL®
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains.
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge.
Effect of wearing a dorsiflexion assist orthosis on mobility, perceived fatigue and exertion during the six-minute walk test in people with multiple sclerosis: a randomised cross-over protocol.
Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
Simvastatin in acute optic neuritis.
Segway use in individuals with multiple sclerosis.
Assessment of changes in immune measures of multiple sclerosis patients treated with laquinimod.

Pages